Ralimetinib dimesylate
CAS: 862507-23-1
Ref. TM-T6047
| 1mg | 41.00 € | ||
| 5mg | 83.00 € | ||
| 10mg | 128.00 € | ||
| 25mg | 236.00 € | ||
| 50mg | 361.00 € | ||
| 100mg | 462.00 € | ||
| 1mL*10mM (DMSO) | 99.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Product Information
Name:
Ralimetinib dimesylate
Synonyms:
- Ralimetinib Mesylate
- Ralimetinib
- LY2228820 dimesylate
- LY2228820
Description:
Ralimetinib dimesylate (LY2228820 dimesylate) is a orally available, p38 MAPK inhibitor with potential anti-inflammatory and antineoplastic activities.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
612.74
Formula:
C24H29FN6·2CH4O3S
Purity:
98% - 99.38%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T6047 Ralimetinib dimesylate
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
